Close Menu

NEW YORK (GenomeWeb) — Cytox said today that it has expanded its research collaboration with the Australian Imaging, Biomarker, and Lifestyle Flagship Study of Ageing (AIBL) to test new algorithms for identifying individuals most at risk for developing Alzheimer's disease (AD).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.